Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
OM
STRONG SELLOutset Medical, Inc. · Healthcare · United States · $75M · Avg Vol: $1M/d
16
StockRankGet insider-trade alerts
Q
31
V
42
M
25
P/E (TTM)
—
ROE
-53.2%
D/E
0.9x
Dividend %
—
Loading 1Y...
PRICE (1Y)-3.8%
SMA 50SMA 200
Close
$4.32
RSI (14)
38.4
52W High
$18.63
From 52W High
0.2%
SCORE BREAKDOWN
Quality
31
ROIC
-26.6%26.4
ROE
-53.2%17.4
GP/Assets
18.1%43.7
Op. Margin
-60.7%20.3
FCF/Assets
-12.9%26.2
Piotroski
239.0
Int. Cover
-4.4x29.2
D/E Ratio
0.91x16.2
Current Ratio
6.29x77.0
Value
42
P/E (TTM)
—N/A
EV/EBITDA
-0.3x25.0
P/FCF
—N/A
P/B
0.7x93.1
P/S
0.6x89.6
Div Yield
—N/A
Momentum
25
52W High %
23%4.6
RS 6M
-23%40.2
SMA 50/200
0.83x23.8
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+20%34.9
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$75M
P/E (Forward)
-1.9x
Gross Margin
40.6%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of OM are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| OM | Outset Medical, Inc.(you) | $75M | 16 | STRONG SELL |
| LNSR | LENSAR, Inc. | $69M | 11 | STRONG SELL |
| MDAI | Spectral AI, Inc. | $52M | 16 | STRONG SELL |
| HYPR | Hyperfine, Inc. | $95M | 13 | STRONG SELL |
| ARAY | Accuray Incorporated | $53M | 18 | STRONG SELL |
| LUNG | Pulmonx Corporation | $53M | 18 | STRONG SELL |
| COCH | Envoy Medical, Inc. | $51M | 14 | STRONG SELL |
| STIM | Neuronetics, Inc. | $120M | 16 | STRONG SELL |
| SERA | Sera Prognostics, Inc. | $80M | 5 | STRONG SELL |
| AVH.AX | AVITA Medical, Inc. | $115M | 20 | SELL |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.6%